Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. Chalmers JD, Burgel PR, Daley CL, De Soyza A, et al. N Engl J Med 2025;392:1569-1581.

Read + Share

Amedeo Smart

Independent Medical Education

Chalmers JD, Burgel PR, Daley CL, De Soyza A, et al. Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. N Engl J Med 2025;392:1569-1581.
PMID: 40267423